Relief Therapeutics Holding AG (RLFTF)

[elllk]

In tonight’s 60 Minutes episode on DARPA inspired attempts to end pandemics forever one highlight was about a woman on dialysis who was in an ICU near death with organ failures and septic shock.

At 3:45 in this episode an interesting discussion begins about use of a dialysis filter:

+++++++++++++++++++++++++++++++++++++++++++++++
Dr. Matt Hepburn: This is a filter that you can put on a dialysis machine.
"Patient 16", a military spouse, was in the ICU, near death with organ failure and septic shock when she was entered into a Defense Department COVID-19 study. Her family allowed us to witness the experimental 4-day treatment.

Dr. Gaeta: She's liberated from veso-active medications and her septic shock resolved. We also see improvements in her markers of inflammation. Those are all positive prognostic signs.

Bill Whitaker: You pass someone's blood through this--

Dr. Matt Hepburn: You pass it through--

Bill Whitaker: --it takes the virus out

Dr. Matt Hepburn: Takes the virus out, and puts the blood back in.
Within days, Patient 16 made a full recovery. The FDA has authorized the filter for emergency use. So far, doctors have used it to treat nearly 300 critically ill patients.
+++++++++++++++++++++++++++++++++++++++++++++++

The term veso-active used above has to be a misspelling of vasoactive. I assume the dialysis filter is designed to be used for many illnesses though I am not sure. It is possible Zyesami VIP is being referred since it is vasoactive.

Vasoactive means affecting the diameter of blood vessels. I don’t know how many medications for COVID might also be said to be vasoactive. Can anyone here make some knowledgeable comments on this issue.

Here is the episode with the discussion beginning at 3:45:

Military programs aiming to end pandemics forever
Bill Whitaker reports on how efforts Pentagon programs has helped in the fight against COVID-19 and may help end pandemics forever.

https://www.cbsnews.com/news/last-pandemic-science-military-60-minutes-2021-04-11/